Enterprise Value
172.9M
Cash
10.09M
Avg Qtr Burn
-4.92M
Short % of Float
4.69%
Insider Ownership
2.78%
Institutional Own.
46.95%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CT-95 Details Solid tumor/s | Phase 1 Initiation | |
CTIM-76 Details Solid tumor/s, Testicular cancer, Cervical cancer, Ovarian cancer | Phase 1 Initiation | |
ONA-XR Details Solid tumor/s, Cancer, Ovarian cancer, Endometrial cancer | Failed Discontinued | |
ONA-XR Details Metastatic breast cancer to brain, ER+/HER2- breast cancer, Breast cancer, Cancer, Solid tumor/s | Failed Discontinued | |
ONA-XR Details Breast cancer, Cancer, Solid tumor/s, Metastatic breast cancer to brain, ER+/HER2- breast cancer | Failed Discontinued |